Decrease in Pneumococcal Otitis Media Cultures With Concomitant Increased Antibiotic Susceptibility in the

Basel Jabarin1, Jacob Pitaro, Tzilia Lazarovitch

  • 1*Department of Otolaryngology-Head and Neck Surgery †Clinical Microbiology Laboratory, Assaf Harofeh Medical Center, Tel Aviv University Sackler School of Medicine, Zerifin, Israel.

Abstract

Insights

Pneumococcal conjugate vaccines (PCVs) significantly reduced Streptococcus pneumoniae (Spn) incidence in children with otitis media. Spn also showed increased susceptibility to common antibiotics following PCV introduction.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Microbiology

Background:

  • Otitis media (OM) is a common childhood infection.
  • Streptococcus pneumoniae (Spn) is a primary cause of OM.
  • The advent of pneumococcal conjugate vaccines (PCVs) aimed to reduce Spn-related diseases.

Purpose of the Study:

  • To evaluate the impact of PCVs on the incidence of Spn in pediatric OM.
  • To assess changes in antibiotic susceptibility patterns of Spn isolates during the PCV era.

Main Methods:

  • Retrospective study of children under 8 with OM and positive Spn cultures (2007-2014).
  • Comparison of Spn incidence and antibiotic susceptibility across pre-PCV, transition, and post-PCV13 periods.
  • Analysis of culture data, demographics, and antibiotic susceptibility testing.

Main Results:

  • A significant downward trend in Spn incidence was observed post-PCV introduction.
  • Spn susceptibility to penicillin, erythromycin, trimethoprim/sulfamethoxazole, and ceftriaxone increased significantly over time.
  • The ratio of observed to expected Spn cultures decreased substantially after PCV implementation.

Conclusions:

  • PCVs effectively reduced the incidence of Spn-causing OM in children.
  • Vaccination with PCVs correlated with improved antibiotic susceptibility in circulating Spn strains.
  • These findings underscore the public health impact of PCV vaccination programs.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...